Search - tctmd.com

Displaying 61 - 80 of 217

Sort: Relevancy | Date

Tirzepatide Provides Sustained BP Reduction in Overweight Adults

News Daily News

Tirzepatide Provides Sustained BP Reduction in Overweight Adults

August 15, 2024

Studies Highlight Rapid Growth of Semaglutide Use, Risks of Some Online Sources

News Daily News

Studies Highlight Rapid Growth of Semaglutide Use, Risks of Some Online Sources

August 12, 2024

Semaglutide May Ease Tobacco Use, Study Suggests

News Daily News

Semaglutide May Ease Tobacco Use, Study Suggests

August 01, 2024

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

News Daily News

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Yael L. Maxwell

August 01, 2024

Coronary Calcium Scoring May Help Get Semaglutide to Highest-Risk Patients

News Conference News SCCT 2024

Coronary Calcium Scoring May Help Get Semaglutide to Highest-Risk Patients

July 22, 2024

No Uptick in Suicidal Thinking With GLP-1 Drugs: Medicare Data

News Daily News

No Uptick in Suicidal Thinking With GLP-1 Drugs: Medicare Data

Yael L. Maxwell

July 15, 2024

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

News Daily News

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

Yael L. Maxwell

July 10, 2024

Think You Need a Statin? AHA’s Risk Calculator May Disagree

News Daily News

Think You Need a Statin? AHA’s Risk Calculator May Disagree

Michael O'Riordan

June 28, 2024

Childhood Risk Factors Predict Later CVD Risk

News Daily News

Childhood Risk Factors Predict Later CVD Risk

June 28, 2024

‘Provocative’ Projections See Semaglutide Slashing CV Events in Adults With ASCVD

News Daily News

‘Provocative’ Projections See Semaglutide Slashing CV Events in Adults With ASCVD

June 27, 2024

Semaglutide Has Similar Benefits in Women and Men With HFpEF

News Daily News

Semaglutide Has Similar Benefits in Women and Men With HFpEF

June 26, 2024

Weight-Loss Drug Tirzepatide Reduces Severity of Obstructive Sleep Apnea

News Daily News

Weight-Loss Drug Tirzepatide Reduces Severity of Obstructive Sleep Apnea

Michael O'Riordan

June 25, 2024

Aspirin for Primary Prevention of CVD Remains Common in US

News Daily News

Aspirin for Primary Prevention of CVD Remains Common in US

June 24, 2024

AHA Celebrates a Century by Looking Back, and Forward

News Daily News

AHA Celebrates a Century by Looking Back, and Forward

June 10, 2024

Don’t Worry About Muscle Loss With GLP-1 Inhibitors, Viewpoint Asserts

News Daily News

Don’t Worry About Muscle Loss With GLP-1 Inhibitors, Viewpoint Asserts

Yael L. Maxwell

June 10, 2024

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

News Daily News

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

June 05, 2024

June 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

June 01, 2024

Data Fail to Support Link Between COVID-19 Vaccines and SCD in Young People

News Daily News

Data Fail to Support Link Between COVID-19 Vaccines and SCD in Young People

April 19, 2024

Tirzepatide Eases Obstructive Sleep Apnea in Patients With Obesity

News Daily News

Tirzepatide Eases Obstructive Sleep Apnea in Patients With Obesity

April 17, 2024

EMA: No Evidence of Link Between GLP-1 Receptor Agonists and Suicidal Thoughts

News Daily News

EMA: No Evidence of Link Between GLP-1 Receptor Agonists and Suicidal Thoughts

April 12, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.